Your browser doesn't support javascript.
loading
New live attenuated tuberculosis vaccine MTBVAC induces trained immunity and confers protection against experimental lethal pneumonia.
Tarancón, Raquel; Domínguez-Andrés, Jorge; Uranga, Santiago; Ferreira, Anaísa V; Groh, Laszlo A; Domenech, Mirian; González-Camacho, Fernando; Riksen, Niels P; Aguilo, Nacho; Yuste, José; Martín, Carlos; Netea, Mihai G.
Afiliação
  • Tarancón R; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain.
  • Domínguez-Andrés J; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain.
  • Uranga S; Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, Nijmegen, the Netherlands.
  • Ferreira AV; Department of Microbiology, Faculty of Medicine, University of Zaragoza, Zaragoza, Spain.
  • Groh LA; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain.
  • Domenech M; Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, Nijmegen, the Netherlands.
  • González-Camacho F; Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal.
  • Riksen NP; Department of Internal Medicine and Radboud Center for Infectious diseases (RCI), Radboud University Nijmegen Medical Centre, Geert Grooteplein 8, Nijmegen, the Netherlands.
  • Aguilo N; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain.
  • Yuste J; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
  • Martín C; CIBERES and Research Network on Respiratory Diseases, Spanish Ministry of Health and Instituto de Salud Carlos III, Madrid, Spain.
  • Netea MG; Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.
PLoS Pathog ; 16(4): e1008404, 2020 04.
Article em En | MEDLINE | ID: mdl-32240273
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Tuberculose / Monócitos / Vacinas contra a Tuberculose / Modelos Animais de Doenças / Imunidade Inata / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pneumonia / Tuberculose / Monócitos / Vacinas contra a Tuberculose / Modelos Animais de Doenças / Imunidade Inata / Mycobacterium tuberculosis Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: PLoS Pathog Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha